Moore, Stephen
Alsop, Eric
Lorenzini, Ileana
Starr, Alexander
Rabichow, Benjamin E.
Mendez, Emily
Levy, Jennifer L.
Burciu, Camelia
Reiman, Rebecca
Chew, Jeannie
Belzil, Veronique V.
Dickson, Dennis
Robertson, Janice
Staats, Kim A.
Ichida, Justin K.
Petrucelli, Leonard
Van Keuren-Jensen, Kendall
Sattler, Rita
Funding for this research was provided by:
National Institute of Neurological Disorders and Stroke (R01NS085207)
Muscular Dystrophy Association
Amyotrophic Lateral Sclerosis Association
Robert Packard Center for ALS Research, Johns Hopkins University
Barrow Neurological Institute
National Institutes of Health (R01NS097850, P01NS084974)
U.S. Department of Defense (W81XWH-15-1-0187)
Donald E. and Delia B. Baxter Foundation
Alzheimer's Drug Discovery Foundation
Association for Frontotemporal Degeneration
Harrington Discovery Institute
Tau Consortium
Judith and Jean Pape Adams Charitable Foundation
Bruno and Ilse Frick Foundation for Research on ALS
New York Stem Cell Foundation
Keck School of Medicine of USC
USC Broad Innovation Award
Southern California Clinical and Translational Science Institute
Richard N. Merkin Scholar
National Institute of Neurological Disorders and Stroke (R35NS097273, P01NS084974, P01NS099114, R01NS088689)
Mayo Clinic
Target ALS
James Hunter Family ALS Initiative
U.S. Department of Veterans Affairs (I01BX003625)
Article History
First Online: 26 September 2019
Free to read: This content has been made available to all.